BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 16108112)

  • 1. [Ovarian cancer: incidence and mortality in France].
    Trétarre B; Remontet L; Ménégoz F; Mace-Lesec'h J; Grosclaude P; Buemi A; Guizard AV; Velten M; Arveux P; Peng J; Jougla E; Laffargue F; Daurès JP
    J Gynecol Obstet Biol Reprod (Paris); 2005 Apr; 34(2):154-61. PubMed ID: 16108112
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ovarian cancer in France: trends in incidence, mortality and survival, 1980-2012.
    Trétarre B; Molinié F; Woronoff AS; Bossard N; Bessaoud F; Marrer E; Grosclaude P; Guizard AV; Delafosse P; Bara S; Velten M; Lapôtre-Ledoux B; Ligier K; Léone N; Arveux P; Uhry Z
    Gynecol Oncol; 2015 Nov; 139(2):324-9. PubMed ID: 26383829
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Incidence and mortality of prostate cancer in France: trends between 1978 and 2000].
    Bauvin E; Remontet L; Grosclaude P; ;
    Prog Urol; 2003 Dec; 13(6):1334-9. PubMed ID: 15000309
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Descriptive epidemiology of gynecologic and breast cancers].
    Schraub S; Alauzet E; Schaffer P; Robillard J; Menegoz F
    Rev Fr Gynecol Obstet; 1992 Dec; 87(12):577-85. PubMed ID: 1485074
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidemiology of ovarian cancer in North Sardinia, Italy, during the period 1992-2010.
    Tanda ET; Budroni M; Cesaraccio R; Palmieri G; Palomba G; Capobianco G; Dessole M; Dessole S; Cossu A
    Eur J Gynaecol Oncol; 2015; 36(1):69-72. PubMed ID: 25872338
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Larynx cancer in France: descriptive epidemiology and incidence estimation].
    Peng J; Ménégoz F; Lesec'h JM; Remontet L; Grosclaude P; Buémi A; Guizard AV; Tretarre B; Danzon A; Velten M; Maarouf N; Jougla E; Launoy G; Dubreuil A
    Bull Cancer; 2004 Apr; 91(4):363-8. PubMed ID: 15242320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ovarian cancer incidence and mortality in Denmark, 1943-1982.
    Ewertz M; Kjaer SK
    Int J Cancer; 1988 Nov; 42(5):690-6. PubMed ID: 3182105
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ovarian cancer incidence (1989-1991) and mortality (1954-1993) in The Netherlands.
    Koper NP; Kiemeney LA; Massuger LF; Thomas CM; Schijf CP; Verbeek AL
    Obstet Gynecol; 1996 Sep; 88(3):387-93. PubMed ID: 8752245
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Incidence and mortality of gynaecological cancers in Guadeloupe (French West Indies)].
    Kadhel P; Janky E; Multigner L
    Bull Cancer; 2009 Feb; 96(2):157-64. PubMed ID: 19258222
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence, mortality, and survival trends of ovarian cancer in Hong Kong, 1997 to 2006: a population-based study.
    Wong KH; Mang OW; Au KH; Law SC
    Hong Kong Med J; 2012 Dec; 18(6):466-74. PubMed ID: 23223646
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ovarian and endometrial cancers.
    Mant JW; Vessey MP
    Cancer Surv; 1994; 19-20():287-307. PubMed ID: 7895220
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer incidence and mortality in France over the 1980-2012 period: solid tumors.
    Binder-Foucard F; Bossard N; Delafosse P; Belot A; Woronoff AS; Remontet L;
    Rev Epidemiol Sante Publique; 2014 Apr; 62(2):95-108. PubMed ID: 24613140
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pattern of mortality from ovarian cancer in France 1968-1991].
    Rezvani A; Lê MG
    Bull Cancer; 1994 Dec; 81(12):1091-5. PubMed ID: 7742598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Worldwide variations in the lifetime probability of reproductive cancer in women: implications of best-case, worst-case, and likely-case assumptions about the effect of oral contraceptive use.
    Petitti DB; Porterfield D
    Contraception; 1992 Feb; 45(2):93-104. PubMed ID: 1559340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trends in the mortality (1950-1997) and incidence (1975-1993) of malignant ovarian neoplasm among Japanese women: analyses by age, time, and birth cohort.
    Tamakoshi K; Kondo T; Yatsuya H; Hori Y; Kikkawa F; Toyoshima H
    Gynecol Oncol; 2001 Oct; 83(1):64-71. PubMed ID: 11585415
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer incidence and mortality in France over the period 1978-2000.
    Remontet L; Estève J; Bouvier AM; Grosclaude P; Launoy G; Menegoz F; Exbrayat C; Tretare B; Carli PM; Guizard AV; Troussard X; Bercelli P; Colonna M; Halna JM; Hedelin G; Macé-Lesec'h J; Peng J; Buemi A; Velten M; Jougla E; Arveux P; Le Bodic L; Michel E; Sauvage M; Schvartz C; Faivre J
    Rev Epidemiol Sante Publique; 2003 Feb; 51(1 Pt 1):3-30. PubMed ID: 12684578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent trends in incidence of and mortality from breast, ovarian and endometrial cancers in England and Wales and their relation to changing fertility and oral contraceptive use.
    dos Santos Silva I; Swerdlow AJ
    Br J Cancer; 1995 Aug; 72(2):485-92. PubMed ID: 7640237
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ovarian cancer in Iranian women, a trend analysis of mortality and incidence.
    Sharifian A; Pourhoseingholi MA; Norouzinia M; Vahedi M
    Asian Pac J Cancer Prev; 2014; 15(24):10787-90. PubMed ID: 25605177
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ovarian cancer in Western Australia (1982-98): incidence, mortality and survival.
    Laurvick CL; Semmens JB; Holman CD; Leung YC
    Aust N Z J Public Health; 2003 Dec; 27(6):588-95. PubMed ID: 14723405
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of historical breastfeeding practices on the incidence of cancer in France in 2015.
    Shield KD; Dossus L; Fournier A; Marant Micallef C; Rinaldi S; Rogel A; Heard I; Pilleron S; Bray F; Soerjomataram I
    Cancer Causes Control; 2018 Mar; 29(3):325-332. PubMed ID: 29464426
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.